ArticleNature cancer2025

A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer.

Zhiren Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.